Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

COX-2 Review Highlights “Conundrum” Of FDA Drug Safety Regulation

Apr 25 2005

• By The Pink Sheet

Related Content

Bextra Withdrawn At FDA’s Request; Pfizer Holds Out Hope For Return

Apr 11 2005

Vioxx Route To Re-Approval Outlined By FDA As Merck Mulls Options

Apr 25 2005

Bextra, Vioxx Require Stronger Warnings, Additional Study, Cmte. Finds

Feb 28 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window